• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT CYCLOSPORINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT CYCLOSPORINE Back to Search Results
Catalog Number 01L75-26
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Patient information: no further patient information was provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed falsely elevated architect cyclosporine results for 2 pediatric patients.The patients are a (b)(6) year old with architect cyclosporine measurements every 2-3 weeks.The results usually are around 100 ng/ml but have been measuring high around 130 ng/ml, 150 ng/ml, and 170ng/ml since (b)(6) 2019.No impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets was performed for architect cyclosporine reagent lot number 01053m800.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Accuracy testing was performed by using internal cyclosporine panels and were tested using retained kits of the likely cause materials.Acceptance criteria were met, which indicates acceptable product performance.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the architect cyclosporine reagent for lot number 01053m800 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT CYCLOSPORINE
Type of Device
CYCLOSPORINE
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key9498088
MDR Text Key219765194
Report Number1415939-2019-00235
Device Sequence Number1
Product Code MKW
UDI-Device Identifier00380740001315
UDI-Public00380740001315
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/14/2020
Device Catalogue Number01L75-26
Device Lot Number01053M800
Was Device Available for Evaluation? No
Date Manufacturer Received01/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR PROCESSING MODULE.; LIST 03M74-01, SERIAL (B)(6).
-
-